1 December 2015 - CADTH has received notice of a pending submission from AstraZeneca for Xigduo (dapagliflozin propanediol monohydrate with metformin hydrochloride) tablets for patients with type 2 diabetes mellitus.

For more details, go to: https://www.cadth.ca/dapagliflozinmetformin-hydrochloride